Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInforma Regulatory News (INF)

Share Price Information for Informa (INF)

Share Price is delayed by 15 minutes
Get Live Data
862.00    21.60 (2.57%)
Bid:
861.60
Ask:
862.00
Spread: 0.40 (0.046%)
Market Cap: £10.82b
INF Live PriceLast checked at - London Stock Exchange

Intraday Informa Share Chart

Trading Update

Today 07:00

RNS Number : 7395I
Informa PLC
18 June 2026
 

Informa LEI: 5493006VM2LKUPSEDU20

Informa PLC Press Release

18 June 2026

AGM Trading Update

Growth in 2026, Stronger Growth into 2027

Informa (LSE: INF.L), the international B2B Live Events, B2B Digital Services and Academic Markets Group today published a trading update to coincide with its AGM, reporting five-month underlying revenue growth of 6.4%.

Stephen A. Carter, Group Chief Executive, Informa, said:

ÓThe depth and breadth of InformaÕs portfolio, both geographically and by market category, continues to deliver growth, international expansion and product and brand innovation.Ó

He added: ÒWe have momentum in both our businesses, B2B Live Events and Academic Services, and are reconfirming full year earnings guidance1.Ó

Highlights

á Growth in 2026... Group underlying revenue growth of 6.4% in the five months to 31 May (excluding non-recurring data access contracts), with continuing strength in both Academic Markets and B2B Live Events:

á Academic Markets: Underlying revenue growth of 5.5% at Taylor & Francis in the first five months (excluding non-recurring data access contracts), with good performances in Subscriptions, Open Research and Advanced Learning. On track for 4% full year underlying growth;

á B2B Live Events (Informa Markets / Connect / Festivals): Underlying revenue growth of 7.6% over first five months:

á Strong B2B growth in The Americas, Greater China, ASEAN, Europe and IMEA pre-conflict (c.90% of B2B Live Events)...Full year underlying revenue growth guidance of 7%+ with more than $1.5bn traded to date. Strong performances in Healthcare (HIMSS, WHX Dubai, WHX Labs), Food (Gulfood, Vitafoods Europe, Natural Products Expo West, National Restaurant Show), Beauty & Aesthetics (Anti-Aging World Congress, Cosmoprof Miami) and Finance (SuperReturn International, Money 20/20 Europe, Finovate), alongside targeted investment in Gaming to reposition the leading brand GDC and launch the KSA brand Kingdom of Gaming;

á Returning B2B growth in markets directly impacted by conflict (c.10% of B2B Live Events still to run)...We will update the market further on 30 July (Interim Results), which will be five weeks ahead of the first major 2026 re-scheduled Brands, LEAP in Riyadh and Middle East Energy in Dubai. 15+ Brands have been rescheduled within 2026 and we have actively deferred to 2027 a number of new event launches, including Food (Vitafoods Dubai), Interior Security (Fortis), and some smaller pre-existing Brands, Health Tech (WHX Tech) and Manufacturing (Gulf Print & Paper);

á Full year visibility...Group revenues of $4bn+ traded, booked or visible for the full year via subscriptions, recurring revenues and forward booked contracts;

á Earnings guidance reaffirmed...We remain committed to full year Group earnings guidance (double-digit underlying growth in adjusted EPS1);

á Stronger growth in 2027...Further strong growth in adjusted EPS:

á Full Brand schedule in 2027...Strong forward visibility and a full year of annual and biennial B2B brands, as well as the restaging of deferred launches and Brands;

á H1 visibility in 2027...Forward revenues for H1 of $0.6bn+ booked or confirmed to date, with annual and biennial B2B Brands pacing to deliver strong growth;

á 2025-2028 One Informa...Four-year programme to maximise InformaÕs B2B growth platform building momentum, focused on Data-led Marketing, Customer Experience, the group-wide deployment of AI technology and driving efficiency, productivity and product innovation;

á Balance sheet strengthÉSignificantly over-subscribed Û500m 6-year Eurobond, extending weighted average debt maturity to 4.3 years and providing long-term financing flexibility; and

á Shareholder Returns... £250m Share Buyback Programme ongoing.

 

Enquiries

Stephen A. Carter, Group Chief Executive

+44 (0) 20 8052 0400

Gareth Wright, Group Finance Director

+44 (0) 20 8052 0400

Richard Menzies-Gow, Director of IR & Communications

+44 (0) 20 8052 2787

Tim Burt / Anthony Di Natale Ð Teneo

+44 (0) 7583 413254 / +44 (0) 7880 715975

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTVDLFFQQLXBBK
Date   Source Headline
7th Jul 20239:34 amRNSHolding(s) in Company
7th Jul 20237:00 amRNSTransaction in Own Shares
6th Jul 20237:00 amRNSTransaction in Own Shares
5th Jul 20237:00 amRNSTransaction in Own Shares
4th Jul 20234:38 pmRNSHolding(s) in Company
4th Jul 20237:00 amRNSTransaction in Own Shares
3rd Jul 20235:03 pmRNSHolding(s) in Company
3rd Jul 202310:03 amRNSTotal Voting Rights
3rd Jul 20237:00 amRNSTransaction in Own Shares
30th Jun 20237:00 amRNSTransaction in Own Shares
29th Jun 20239:53 amRNSHolding(s) in Company
29th Jun 20237:00 amRNSTransaction in Own Shares
28th Jun 20237:00 amRNSTransaction in Own Shares
27th Jun 20237:00 amRNSTransaction in Own Shares
26th Jun 20237:00 amRNSTransaction in Own Shares
23rd Jun 20237:00 amRNSTransaction in Own Shares
22nd Jun 202311:15 amRNSHolding(s) in Company
22nd Jun 20237:00 amRNSTransaction in Own Shares
21st Jun 20237:00 amRNSTransaction in Own Shares
20th Jun 20232:20 pmRNSDirector/PDMR Shareholding
20th Jun 20237:00 amRNSTransaction in Own Shares
19th Jun 20238:07 amRNSHolding(s) in Company
19th Jun 20237:00 amRNSTransaction in Own Shares
16th Jun 20237:00 amRNSTransaction in Own Shares
15th Jun 20233:37 pmRNSResult of AGM
15th Jun 20237:00 amRNSAccelerating Growth
15th Jun 20237:00 amRNSTransaction in Own Shares
14th Jun 20235:19 pmRNSHolding(s) in Company
14th Jun 20237:00 amRNSTransaction in Own Shares
13th Jun 20237:00 amRNSTransaction in Own Shares
12th Jun 20233:47 pmRNSHolding(s) in Company
12th Jun 20237:00 amRNSTransaction in Own Shares
9th Jun 20235:43 pmRNSHolding(s) in Company
9th Jun 20237:00 amRNSTransaction in Own Shares
8th Jun 20235:54 pmRNSHolding(s) in Company
8th Jun 202310:18 amRNSHolding(s) in Company
8th Jun 20237:00 amRNSTransaction in Own Shares
7th Jun 20239:44 amRNSHolding(s) in Company
7th Jun 20237:00 amRNSTransaction in Own Shares
6th Jun 20237:00 amRNSTransaction in Own Shares
5th Jun 20235:41 pmRNSHolding(s) in Company
5th Jun 20235:37 pmRNSHolding(s) in Company
5th Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSTransaction in Own Shares
2nd Jun 20237:00 amRNSHolding(s) in Company
1st Jun 20239:10 amRNSTotal Voting Rights
1st Jun 20237:00 amRNSTransaction in Own Shares
31st May 20237:00 amRNSTransaction in Own Shares
30th May 20237:00 amRNSTransaction in Own Shares
26th May 20234:07 pmRNSDirector Declaration

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.